Standout Papers

Pan-cancer adaptive immune resistance as defined by the Tumor Inflammation Signature (TIS): results from... 2018 2026 2020 2023 289
  1. Pan-cancer adaptive immune resistance as defined by the Tumor Inflammation Signature (TIS): results from The Cancer Genome Atlas (TCGA) (2018)
    Patrick Danaher, Sarah Warren et al. Journal for ImmunoTherapy of Cancer

Immediate Impact

1 by Nobel laureates 6 from Science/Nature 70 standout
Sub-graph 1 of 22

Citing Papers

A broad-spectrum lasso peptide antibiotic targeting the bacterial ribosome
2025 StandoutNature
Probiotic neoantigen delivery vectors for precision cancer immunotherapy
2024 StandoutNature
2 intermediate papers

Works of Amy Sullivan being referenced

Pan-cancer adaptive immune resistance as defined by the Tumor Inflammation Signature (TIS): results from The Cancer Genome Atlas (TCGA)
2018 Standout
Mycofactocin-associated mycobacterial dehydrogenases with non-exchangeable NAD cofactors
2017

Author Peers

Author Last Decade Papers Cites
Amy Sullivan 253 158 107 123 16 373
Guangyu An 255 139 105 115 24 407
Lena Horvath 269 127 149 159 17 427
Ignazio Martellucci 273 103 64 66 16 346
Ekaterini Politi 215 71 167 127 15 418
Chukwuemeka Ikpeazu 181 139 116 44 23 340
Daniele Pozzessere 226 170 111 102 24 416
Sarah Morgan 231 106 149 87 12 416
Eva Markert 179 163 81 62 19 396
Andrew E. Filderman 113 171 112 66 21 403
Jinen Song 206 58 152 144 14 395

All Works

Loading papers...

Rankless by CCL
2026